Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name C188-9
Trade Name
Synonyms TTI101|TTI-101|TTI 101
Drug Descriptions

C188-9 (TTI-101) is a small molecule that binds to STAT3 and inhibits signaling, potentially resulting in tumor cell death (PMID: 27027445, PMID: 32475130).

DrugClasses STAT3 Inhibitor 26
CAS Registry Number 432001-19-9
NCIT ID C151932


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Bevacizumab + C188-9 Atezolizumab Bevacizumab C188-9 0 1
C188-9 C188-9 0 4
C188-9 + Fulvestrant C188-9 Fulvestrant 0 1
C188-9 + Palbociclib C188-9 Palbociclib 0 1
C188-9 + Pembrolizumab C188-9 Pembrolizumab 0 1
C188-9 + Ribociclib C188-9 Ribociclib 0 1

Additional content available in CKB BOOST